GHK-CU 50mg

About GHK-CU 50mg

GHK-Cu is a naturally occurring copper-binding tripeptide composed of glycine-histidine-lysine with a bound copper(II) ion. First isolated from human plasma by Loren Pickart in 1973, GHK-Cu was identified during studies comparing the bioactivity of plasma from younger versus older donors. The copper ion is not incidental — it is essential to the peptide’s biological activity, forming a high-affinity complex that enables GHK-Cu to participate in copper-dependent enzymatic processes and cellular signalling pathways.

In research settings, GHK-Cu has attracted sustained interest for its involvement in collagen synthesis, wound remodelling, anti-inflammatory signalling, and antioxidant enzyme regulation. Studies have demonstrated its capacity to modulate superoxide dismutase (SOD) activity and glutathione levels, positioning it as a compound of broad relevance across regenerative biology, dermatological research, and age-related tissue studies. Its relatively small size and well-characterised binding chemistry make it a practical tool for investigating copper-mediated biological processes in both in vitro and in vivo models.

Perhaps most striking is the scope of its influence at the gene expression level. Work by Pickart and Campbell using genome-wide profiling revealed that GHK-Cu affects the expression of approximately 4,000 human genes — resetting patterns associated with tissue damage and ageing toward profiles more characteristic of healthy tissue. This breadth of activity has made GHK-Cu a focal point for researchers exploring how a single small molecule can coordinate complex, multi-pathway biological responses.

Research Summary

The foundational research on GHK-Cu traces back to Pickart’s 1973 discovery that a low-molecular-weight factor in young human plasma could stimulate aged liver tissue to synthesise proteins at rates comparable to younger tissue. Subsequent isolation and characterisation identified the active factor as the tripeptide glycyl-L-histidyl-L-lysine in complex with copper(II). This early work established the principle that GHK-Cu acts as a signalling molecule rather than simply a structural component, setting the stage for decades of investigation across multiple research domains.

Wound healing and tissue remodelling represent one of the most thoroughly studied areas of GHK-Cu research. Studies using animal wound models have demonstrated that GHK-Cu accelerates wound contraction, stimulates collagen deposition, and promotes angiogenesis — the formation of new blood vessels in damaged tissue. Research published by Pickart, Downey, and colleagues showed that GHK-Cu-treated wounds in rodent models exhibited increased collagen synthesis and more organised extracellular matrix architecture compared to controls. These effects appear to be mediated in part through the recruitment and activation of fibroblasts, the primary collagen-producing cells in connective tissue.

The anti-inflammatory and antioxidant properties of GHK-Cu have been explored extensively in cell culture and animal studies. Research has shown that GHK-Cu suppresses markers of oxidative stress by upregulating antioxidant enzymes including superoxide dismutase and by modulating glutathione metabolism. Work by Canapp and colleagues demonstrated anti-inflammatory effects in rodent lung injury models, where GHK-Cu reduced markers of acute inflammation. These findings have positioned GHK-Cu as a compound of interest in research on oxidative damage, chronic inflammation, and tissue protection.

In skin biology, GHK-Cu has been studied for its effects on fibroblast proliferation, dermal remodelling, and hair follicle cycling. In vitro studies have shown that GHK-Cu stimulates fibroblast production of collagen, decorin, and other extracellular matrix components. Research on hair biology, including work by Pyo and colleagues, has examined the effects of copper peptides on hair follicle size and growth cycle regulation in animal models, with findings suggesting that GHK-Cu may promote the transition of follicles from the resting (telogen) phase to the active growth (anagen) phase.

The gene expression work by Pickart and Campbell, published through the Broad Institute’s Connectivity Map dataset analysis, represents a significant contribution to understanding GHK-Cu’s mechanism. Their analysis revealed that GHK-Cu modulates approximately 4,000 human genes, with notable effects on genes involved in DNA repair, antioxidant defence, the ubiquitin-proteasome system, and the suppression of pro-inflammatory pathways such as NF-kB signalling. This work suggested that GHK-Cu acts as a broad-spectrum restorative signal rather than a single-pathway agonist — a finding that has informed subsequent research directions.

Emerging areas of GHK-Cu research include neuroprotection and bone regeneration. Preliminary studies in cell culture models have explored GHK-Cu’s potential to support neuronal survival under conditions of oxidative stress, while in vivo bone studies have investigated its capacity to enhance osteoblast activity and mineral deposition. These newer research lines remain at earlier stages but reflect the growing recognition that GHK-Cu’s multi-target activity profile may have relevance well beyond its traditional association with skin and wound biology. All findings discussed pertain to in vitro and animal model research; this product is supplied strictly for research use only.